Joseph A Kaufman
Examiner (ID: 10129)
Most Active Art Unit | 3754 |
Art Unit(s) | 3752, 3993, 3727, 3754, 3108, 3104 |
Total Applications | 1964 |
Issued Applications | 1543 |
Pending Applications | 181 |
Abandoned Applications | 196 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 122132
[patent_doc_number] => 07709617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-04
[patent_title] => 'Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy'
[patent_app_type] => utility
[patent_app_number] => 11/173983
[patent_app_country] => US
[patent_app_date] => 2005-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 37
[patent_no_of_words] => 20812
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/709/07709617.pdf
[firstpage_image] =>[orig_patent_app_number] => 11173983
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/173983 | Synergistic stimulation of the immune system using immunostimulatory oligonucleotides and/or immunomer compounds in conjunction with cytokines and/or chemotherapeutic agents or radiation therapy | Jun 30, 2005 | Issued |
Array
(
[id] => 5720352
[patent_doc_number] => 20060073126
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Cytotoxic T lymphocyte'
[patent_app_type] => utility
[patent_app_number] => 11/171365
[patent_app_country] => US
[patent_app_date] => 2005-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12410
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20060073126.pdf
[firstpage_image] =>[orig_patent_app_number] => 11171365
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/171365 | Cytotoxic T lymphocyte | Jun 30, 2005 | Abandoned |
Array
(
[id] => 891675
[patent_doc_number] => 07344883
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-18
[patent_title] => 'Complementing cell lines'
[patent_app_type] => utility
[patent_app_number] => 11/165697
[patent_app_country] => US
[patent_app_date] => 2005-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 24569
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/344/07344883.pdf
[firstpage_image] =>[orig_patent_app_number] => 11165697
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/165697 | Complementing cell lines | Jun 23, 2005 | Issued |
Array
(
[id] => 4745271
[patent_doc_number] => 20080089873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'Method for Regenerating Hair Follicles by Suppressing a Gene with Hair Follicle Formation-Inhibiting Ability or by Activating a Gene with Hair Follicle Formation-Inducing Ability'
[patent_app_type] => utility
[patent_app_number] => 11/629281
[patent_app_country] => US
[patent_app_date] => 2005-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8553
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20080089873.pdf
[firstpage_image] =>[orig_patent_app_number] => 11629281
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/629281 | Method for Regenerating Hair Follicles by Suppressing a Gene with Hair Follicle Formation-Inhibiting Ability or by Activating a Gene with Hair Follicle Formation-Inducing Ability | Jun 9, 2005 | Abandoned |
Array
(
[id] => 4476646
[patent_doc_number] => 07906312
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-15
[patent_title] => 'Viral vectors whose replication and, optionally, passenger gene are controlled by a gene switch activated by heat in the presence or absence of a small-molecule regulator'
[patent_app_type] => utility
[patent_app_number] => 11/148368
[patent_app_country] => US
[patent_app_date] => 2005-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 10
[patent_no_of_words] => 14955
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/906/07906312.pdf
[firstpage_image] =>[orig_patent_app_number] => 11148368
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/148368 | Viral vectors whose replication and, optionally, passenger gene are controlled by a gene switch activated by heat in the presence or absence of a small-molecule regulator | Jun 8, 2005 | Issued |
Array
(
[id] => 6931238
[patent_doc_number] => 20050282273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Medium and methods for culturing of avian primordial germ cells'
[patent_app_type] => utility
[patent_app_number] => 11/148039
[patent_app_country] => US
[patent_app_date] => 2005-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8868
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282273.pdf
[firstpage_image] =>[orig_patent_app_number] => 11148039
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/148039 | Medium and methods for culturing of avian primordial germ cells | Jun 7, 2005 | Abandoned |
Array
(
[id] => 5705704
[patent_doc_number] => 20060194752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Treatment for renal disease'
[patent_app_type] => utility
[patent_app_number] => 11/147500
[patent_app_country] => US
[patent_app_date] => 2005-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 11806
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20060194752.pdf
[firstpage_image] =>[orig_patent_app_number] => 11147500
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/147500 | Treatment for renal disease | Jun 6, 2005 | Abandoned |
Array
(
[id] => 4431723
[patent_doc_number] => 07968334
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-28
[patent_title] => 'Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing'
[patent_app_type] => utility
[patent_app_number] => 11/141447
[patent_app_country] => US
[patent_app_date] => 2005-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 57
[patent_no_of_words] => 19047
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/968/07968334.pdf
[firstpage_image] =>[orig_patent_app_number] => 11141447
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/141447 | Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing | May 30, 2005 | Issued |
Array
(
[id] => 5819966
[patent_doc_number] => 20060024279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Retroviral vectors'
[patent_app_type] => utility
[patent_app_number] => 11/139766
[patent_app_country] => US
[patent_app_date] => 2005-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6843
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024279.pdf
[firstpage_image] =>[orig_patent_app_number] => 11139766
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/139766 | Retroviral vectors | May 26, 2005 | Abandoned |
Array
(
[id] => 6958372
[patent_doc_number] => 20050214742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Screen for CDC7 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/129586
[patent_app_country] => US
[patent_app_date] => 2005-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8894
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20050214742.pdf
[firstpage_image] =>[orig_patent_app_number] => 11129586
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/129586 | Screen for CDC7 inhibitors | May 12, 2005 | Abandoned |
Array
(
[id] => 5738493
[patent_doc_number] => 20060008884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Hybrid adenovirus/adeno-associated virus vectors and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/127832
[patent_app_country] => US
[patent_app_date] => 2005-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21043
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20060008884.pdf
[firstpage_image] =>[orig_patent_app_number] => 11127832
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/127832 | Hybrid adenovirus/adeno-associated virus vectors and methods of use thereof | May 11, 2005 | Issued |
Array
(
[id] => 5776312
[patent_doc_number] => 20060104952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Genomic barrier to viral disease'
[patent_app_type] => utility
[patent_app_number] => 11/124312
[patent_app_country] => US
[patent_app_date] => 2005-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 8566
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20060104952.pdf
[firstpage_image] =>[orig_patent_app_number] => 11124312
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/124312 | Genomic barrier to viral disease | May 5, 2005 | Abandoned |
Array
(
[id] => 5769527
[patent_doc_number] => 20050266020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Modular transport systems for molecular substances and production and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/120543
[patent_app_country] => US
[patent_app_date] => 2005-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 11612
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20050266020.pdf
[firstpage_image] =>[orig_patent_app_number] => 11120543
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/120543 | Modular transport systems for molecular substances and production and use thereof | May 1, 2005 | Abandoned |
Array
(
[id] => 5793488
[patent_doc_number] => 20060014169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Methods for obtaining directionally truncated polypeptides'
[patent_app_type] => utility
[patent_app_number] => 11/093387
[patent_app_country] => US
[patent_app_date] => 2005-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15203
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014169.pdf
[firstpage_image] =>[orig_patent_app_number] => 11093387
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/093387 | Methods for obtaining directionally truncated polypeptides | Mar 29, 2005 | Issued |
Array
(
[id] => 10629788
[patent_doc_number] => 09347936
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-24
[patent_title] => 'Inactive Ca2+/calmodulin-dependent protein kinase IIα knockin animal and knockin cell of the same'
[patent_app_type] => utility
[patent_app_number] => 10/599460
[patent_app_country] => US
[patent_app_date] => 2005-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 6911
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10599460
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/599460 | Inactive Ca2+/calmodulin-dependent protein kinase IIα knockin animal and knockin cell of the same | Mar 23, 2005 | Issued |
Array
(
[id] => 5894912
[patent_doc_number] => 20060003451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus'
[patent_app_type] => utility
[patent_app_number] => 11/075385
[patent_app_country] => US
[patent_app_date] => 2005-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7135
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20060003451.pdf
[firstpage_image] =>[orig_patent_app_number] => 11075385
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/075385 | Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus | Mar 7, 2005 | Abandoned |
Array
(
[id] => 6931245
[patent_doc_number] => 20050282280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Oncolytic adenoviral vectors encoding GM-CSF'
[patent_app_type] => utility
[patent_app_number] => 11/066480
[patent_app_country] => US
[patent_app_date] => 2005-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 27044
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0282/20050282280.pdf
[firstpage_image] =>[orig_patent_app_number] => 11066480
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/066480 | Oncolytic adenoviral vectors encoding GM-CSF | Feb 27, 2005 | Abandoned |
Array
(
[id] => 7077731
[patent_doc_number] => 20050150003
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Method for improving phytoremediation treatment of a contaminated medium'
[patent_app_type] => utility
[patent_app_number] => 11/056502
[patent_app_country] => US
[patent_app_date] => 2005-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6836
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20050150003.pdf
[firstpage_image] =>[orig_patent_app_number] => 11056502
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/056502 | Method for improving phytoremediation treatment of a contaminated medium | Feb 10, 2005 | Abandoned |
Array
(
[id] => 7110609
[patent_doc_number] => 20050208064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide'
[patent_app_type] => utility
[patent_app_number] => 11/050679
[patent_app_country] => US
[patent_app_date] => 2005-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6108
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208064.pdf
[firstpage_image] =>[orig_patent_app_number] => 11050679
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/050679 | Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide | Feb 6, 2005 | Abandoned |
Array
(
[id] => 6977832
[patent_doc_number] => 20050287550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Bacterial counterselectable hybrid systems'
[patent_app_type] => utility
[patent_app_number] => 11/050174
[patent_app_country] => US
[patent_app_date] => 2005-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 23116
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20050287550.pdf
[firstpage_image] =>[orig_patent_app_number] => 11050174
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/050174 | Bacterial counterselectable hybrid systems | Feb 1, 2005 | Issued |